Technology developed by a team of scientists at Dartmouth, including faculty, postdoctoral researchers, and graduate students, that contributed to the development of COVID-19 vaccines will allow Dartmouth to make major investments into advancing its research and education enterprise.
Creator of breakthrough coronavirus technology will be awarded $100,000 at Dartmouth on May 13.
Findings from a new study, led by researchers at Dartmouth’s Geisel School of Medicine and published in JAMA Neurology, show that higher death rates have been associated with the COVID-19 pandemic among older adults with cognitive impairment—especially in racial and ethnic minority populations and those living in nursing homes.
A new study by researchers at Dartmouth, Carnegie Mellon University, the University of Pittsburgh, and the Lisa Schwartz Foundation for Truth in Medicine, published in JAMA Internal Medicine, shows that people using COVID home test kits may fail to self-quarantine or may quarantine unnecessarily because they misinterpret the implications of test results.
A team of researchers and clinicians at Geisel and Dartmouth-Hitchcock has begun working together on a National Institutes of Health grant to track the development and spread of COVID-19 variants that are detected in the Upper Valley.
A team of researchers at Dartmouth’s Geisel School of Medicine, led by Glyn Elwyn, MD, PhD, MSc, and Marie-Anne Durand, PhD, has received a $6.2 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to test approaches that may increase confidence in the COVID-19 vaccine among those working in long-term care facilities.
Discoveries originating in a basic science lab at the Geisel School of Medicine are being used in the newly approved COVID-19 vaccine from the Pfizer/BioNTech partnership.
Researchers at Dartmouth’s Geisel School of Medicine have been awarded $2.4 million in federal funding to support ongoing studies aimed at enhancing American healthcare providers’ response to the COVID-19 pandemic.
A new Dartmouth study in Health Affairs examines how hospital admissions during the rebound from the initial COVID-19 onset varies by age, insurance coverage and socioeconomic groups.
Both first- and second-year Geisel medical students completed their required 14-day quarantines and screening PCR testing per Dartmouth policy. As of this week, we are happy to report that there are no positive tests among our medical or graduate students. Thanks to everyone for their continued commitment to the safety of our community.
Upcoming EventsThis page may link to PDF files. Use this link to download Adobe Reader if needed.